基本信息
浏览量:6
职业迁徙
个人简介
International leader in clinical research in leukemia and prolific clinical investigator. Author and coauthor of nearly 1,000 journal articles. Developer of the second generation tyrosine kinase inhibitor bosutinib and the third generation ponatinib, which are widely used today, as well as, omacetaxine, a drug approved for patients with chronic myeloid leukemia where tyrosine kinase inhibitors have stopped working. Most recently, led the development of glasdegib, a smoothened inhibitor approved for the treatment of older patients who have acute myeloid leukemia as well as other conditions, like heart disease or moderate kidney disease, that preclude use of standard intensive induction chemotherapy. Current research emphasis includes development of new therapies for leukemia, developing predictive models, reducing the toxicity of cancer therapy, and improving quality of life of patients with leukemia.
研究兴趣
论文共 2311 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Expert review of hematologyno. 6 (2024): 211-221
Lukas Veltmaat,Jorge Cortes
Bloodno. 10 (2024): 858-865
Richard F. Schlenk,Pau Montesinos, Antonio Romero-Aguilar,Radovan Vrhovac, Elżbieta Patkowska,Hee-Je Kim,Павел Зак,Po‐Nan Wang,James Hanyok, LI Liu,Yasser Mostafa Kamel,Aziz Benzohra,
HemaSphereno. S3 (2023): e61150fb-e61150fb
引用0浏览0引用
0
0
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): TPS7082-TPS7082
引用0浏览0引用
0
0
Bloodno. 9 (2023): 846-855
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): e19041-e19041
引用0浏览0引用
0
0
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S521-S522
Ellin Berman, Neil P Shah, Michael Deninger,Jessica K Altman, Maria Amaya, Kebede Begna,Ravi Bhatia, Onyee Chan, Robert Collins,Peter Curtin,Daniel J DeAngelo, Michael Drazer,
Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 9 (2023): 984-986
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn